Can coca tea (mate de coca) help treat postural orthostatic intolerance?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Coca Tea (Mate de Coca) for Postural Orthostatic Intolerance

Coca tea should not be used to treat postural orthostatic tachycardia syndrome (POTS) or other forms of postural orthostatic intolerance, as there is no evidence supporting its efficacy and one study specifically demonstrates it does not prevent orthostatic symptoms.

Evidence Against Coca Tea

The only available study examining coca leaf tea for orthostatic symptoms found no protective effect. In a cohort of 142 travelers to high altitude (Cusco, Peru at 3350m), 34% consumed coca leaf tea for prevention of acute mountain sickness (which shares orthostatic intolerance features), yet consumption was not associated with decreased risk of developing symptoms 1. This directly contradicts any theoretical benefit for postural orthostatic conditions.

Evidence-Based Treatment Approach

The 2020 Canadian Cardiovascular Society guidelines provide a clear algorithmic approach for managing POTS and orthostatic intolerance 2:

First-Line Non-Pharmacological Interventions

Start with these measures before considering medications:

  • Withdraw aggravating substances: Eliminate any medications or substances that worsen orthostatic tachycardia or symptoms (Strong Recommendation) 2

  • Volume expansion (Strong Recommendation) 2:

    • Increase daily fluid intake to at least 3 liters
    • Increase daily sodium intake to 10 grams via high-salt foods, salt tablets, or salt sticks
  • Exercise training (Strong Recommendation, Moderate-Quality Evidence) 2:

    • Begin in semi-recumbent position (rowing machines, recumbent cycles, swimming)
    • At least 4 days per week, minimum 30 minutes per session
    • May take 4-6 weeks to see improvement
    • Can achieve symptom remission in a proportion of patients
  • Compression garments (Weak Recommendation) 2:

    • Use waist-high compression stockings or abdominal binders
    • Start with 20-30 mm Hg pressure, increase as tolerated
    • Compression below thighs is ineffective
  • Positional strategies 2:

    • Sleep with head elevated >10° to promote volume expansion
    • Learn counter-pressure maneuvers for acute symptoms
    • Avoid warm environments and prolonged standing

Second-Line Pharmacological Interventions

If symptoms persist despite non-pharmacological measures:

  • Midodrine (Strong Recommendation, Moderate-Quality Evidence) 2:

    • Dose: 2.5-15 mg every 4 hours, up to 3 times daily
    • Most beneficial for patients with hypotensive tendency
    • Less effective in hyperadrenergic phenotypes
  • Low-dose propranolol (Strong Recommendation, Moderate-Quality Evidence) 2:

    • Dose: 10-20 mg four times daily (non-selective β-blocker)
    • Reduces standing heart rate and improves exercise capacity
    • Avoid high doses and long-acting formulations (ineffective for symptoms)
    • Most beneficial for patients with high standing heart rates
    • Caution: May worsen exercise tolerance and fatigue
  • Pyridostigmine 2:

    • Peripheral acetylcholinesterase inhibitor
    • Often combined with β-blocker
    • Common side effect: diarrhea (may benefit constipated patients)
  • Fludrocortisone 2:

    • For patients unable to optimize oral salt intake
    • Monitor electrolytes, especially potassium
    • Avoid in migraine patients
  • Acute IV saline bolus (Weak Recommendation) 2:

    • 1-2 liters over 1-2 hours as rescue therapy
    • Not recommended for chronic treatment due to infection/thrombosis risks

Critical Caveats

  • No pharmacologic therapies are currently approved specifically for POTS in Canada 2
  • No single treatment is effective in all patients 2
  • Treatment requires individualized combination strategies based on phenotype (hypotensive vs. hyperadrenergic) 2
  • Recent systematic reviews confirm limited high-quality evidence, with most trials being small 3, 4

The bottom line: Coca tea has no role in treating postural orthostatic intolerance. Begin with volume expansion, salt supplementation, and exercise training, then add midodrine or low-dose propranolol if symptoms persist.

Related Questions

What alternative treatments for anxiety are appropriate in a patient with a history of postural orthostatic tachycardia syndrome (POTS) when propranolol is contraindicated due to hypotension?
What antihistamines are recommended for managing symptoms of postural orthostatic tachycardia syndrome (POTS)?
How does alcohol consumption affect patients with postural orthostatic tachycardia syndrome (POTS) and what are the recommended limits and precautions?
In a patient with suspected postural orthostatic tachycardia syndrome (POTS) and hypermobility who is taking lisdexamfetamine (LDX) 70 mg daily and venlafaxine extended‑release (XR) ≥150 mg daily, is it appropriate to add a low‑dose (5–10 mg) immediate‑release dexamphetamine in the early morning to improve alertness before LDX takes effect, and how should it be titrated and monitored?
Is atomoxetine safe for a patient with postural orthostatic tachycardia syndrome (POTS), and what precautions or alternative treatments should be considered?
Is lip biting the same condition as excoriation (skin‑picking) disorder?
What symptoms or signs should prompt evaluation for progression of monoclonal gammopathy of undetermined significance (MGUS) to a plasma‑cell or lymphoid malignancy?
What are the differences between substance use, substance misuse, substance abuse, and substance dependence?
What is the recommended management for an asymptomatic pituitary cyst less than 10 mm in size?
Does coca tea raise blood pressure?
Are connective tissue disorders such as systemic lupus erythematosus, scleroderma, and mixed connective tissue disease becoming more prevalent?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.